Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Dunlap

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Cardiac Failure|July 6, 2016
Measuring Congestion in Acute Heart Failure: The "Holy Grail" Still AwaitsKhalil Murad, Mark E Dunlap
Cleveland Clinic Journal of Medicine|September 29, 2004
Angiotensin-receptor blockers in heart failure: evidence from the CHARM trialShyam Bhakta, Mark E Dunlap
Current Treatment Options in Cardiovascular Medicine|November 15, 2005
Aldosterone antagonists in the treatment and prevention of heart failureRebecca S Boxer, Mark E Dunlap
Cleveland Clinic Journal of Medicine|May 23, 2002
ACE inhibitors vs ARBs: is one class better for heart failureMark E Dunlap, Ross C Peterson
Congestive Heart Failure (Greenwich, Conn.)|October 9, 2002
Angiotensin II receptor blockers in the treatment of heart failureRoss C Peterson, Mark E Dunlap
Journal of the American College of Cardiology|April 23, 2013
Fluid re-distribution rather than accumulation causes most cases of decompensated heart failureMark E Dunlap, Paul A Sobotka
Journal of the American College of Cardiology|October 20, 2012
Efficiently doing the wrong thingMark E Dunlap, Paul A Sobotka
Current Cardiology Reports|April 13, 2004
Is heart failure different on the two continents (North America and Europe)?Rachel Hughes-Doichev, Mark E Dunlap
Current Cardiology Reports|May 4, 2005
Management of heart failure with pulmonary hypertensionMohammed Najeeb Osman, Mark E Dunlap
Current Heart Failure Reports|July 23, 2005
Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?Osama A Ibrahim, Mark E Dunlap
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Cardiac Failure|July 6, 2016
Measuring Congestion in Acute Heart Failure: The "Holy Grail" Still AwaitsKhalil Murad, Mark E Dunlap
Cleveland Clinic Journal of Medicine|September 29, 2004
Angiotensin-receptor blockers in heart failure: evidence from the CHARM trialShyam Bhakta, Mark E Dunlap
Current Treatment Options in Cardiovascular Medicine|November 15, 2005
Aldosterone antagonists in the treatment and prevention of heart failureRebecca S Boxer, Mark E Dunlap
Cleveland Clinic Journal of Medicine|May 23, 2002
ACE inhibitors vs ARBs: is one class better for heart failureMark E Dunlap, Ross C Peterson
Congestive Heart Failure (Greenwich, Conn.)|October 9, 2002
Angiotensin II receptor blockers in the treatment of heart failureRoss C Peterson, Mark E Dunlap
Journal of the American College of Cardiology|April 23, 2013
Fluid re-distribution rather than accumulation causes most cases of decompensated heart failureMark E Dunlap, Paul A Sobotka
Journal of the American College of Cardiology|October 20, 2012
Efficiently doing the wrong thingMark E Dunlap, Paul A Sobotka
Current Cardiology Reports|April 13, 2004
Is heart failure different on the two continents (North America and Europe)?Rachel Hughes-Doichev, Mark E Dunlap
Current Cardiology Reports|May 4, 2005
Management of heart failure with pulmonary hypertensionMohammed Najeeb Osman, Mark E Dunlap
Current Heart Failure Reports|July 23, 2005
Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?Osama A Ibrahim, Mark E Dunlap
Pageof 6